1. Home
  2. INTS vs VNCE Comparison

INTS vs VNCE Comparison

Compare INTS & VNCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • VNCE
  • Stock Information
  • Founded
  • INTS 2012
  • VNCE 2002
  • Country
  • INTS United States
  • VNCE United States
  • Employees
  • INTS N/A
  • VNCE N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • VNCE Clothing/Shoe/Accessory Stores
  • Sector
  • INTS Health Care
  • VNCE Consumer Discretionary
  • Exchange
  • INTS Nasdaq
  • VNCE Nasdaq
  • Market Cap
  • INTS 33.4M
  • VNCE 38.3M
  • IPO Year
  • INTS 2023
  • VNCE 2013
  • Fundamental
  • Price
  • INTS $2.23
  • VNCE $2.59
  • Analyst Decision
  • INTS Strong Buy
  • VNCE Strong Buy
  • Analyst Count
  • INTS 3
  • VNCE 2
  • Target Price
  • INTS $8.50
  • VNCE $4.50
  • AVG Volume (30 Days)
  • INTS 26.6K
  • VNCE 306.0K
  • Earning Date
  • INTS 03-13-2025
  • VNCE 12-10-2024
  • Dividend Yield
  • INTS N/A
  • VNCE N/A
  • EPS Growth
  • INTS N/A
  • VNCE N/A
  • EPS
  • INTS N/A
  • VNCE 0.37
  • Revenue
  • INTS N/A
  • VNCE $288,813,000.00
  • Revenue This Year
  • INTS N/A
  • VNCE N/A
  • Revenue Next Year
  • INTS N/A
  • VNCE $5.81
  • P/E Ratio
  • INTS N/A
  • VNCE $7.02
  • Revenue Growth
  • INTS N/A
  • VNCE N/A
  • 52 Week Low
  • INTS $1.50
  • VNCE $1.27
  • 52 Week High
  • INTS $5.94
  • VNCE $6.89
  • Technical
  • Relative Strength Index (RSI)
  • INTS 49.26
  • VNCE 38.46
  • Support Level
  • INTS $1.84
  • VNCE $2.70
  • Resistance Level
  • INTS $2.27
  • VNCE $3.04
  • Average True Range (ATR)
  • INTS 0.28
  • VNCE 0.28
  • MACD
  • INTS -0.01
  • VNCE -0.08
  • Stochastic Oscillator
  • INTS 56.36
  • VNCE 8.18

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.

Share on Social Networks: